According to DSM‑5, what is a recognized subtype of sexual dysfunction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

DSM-5 Sexual Dysfunction Subtypes

According to DSM-5, sexual dysfunctions are classified into specific subtypes based on the phase of sexual response affected, including erectile disorder, premature ejaculation, female sexual interest/arousal disorder, and hypoactive sexual desire disorder, among others.

Primary Classification Framework

The DSM-5 organizes sexual dysfunctions according to the sexual response cycle phases originally characterized by Masters and Johnson: desire, arousal, orgasm, and resolution 1. This represents a fundamental shift from DSM-IV's artificial distinction between "organic" and "non-organic" conditions 2.

Recognized Subtypes

Male Sexual Dysfunctions

  • Erectile Disorder (ED): Defined as the consistent or recurrent inability to attain and/or maintain penile erection sufficient for sexual satisfaction, conceptualized as an impairment in the arousal phase 1

  • Premature Ejaculation (PE): Ejaculation that occurs sooner than desired, either before or shortly after penetration, causing distress to either one or both partners. This is further subclassified into:

    • Primary (lifelong): Begins when a male first becomes sexually active
    • Secondary (acquired): Develops after a period of normal function 3
  • Hypoactive Sexual Desire Disorder (HSDD) in men: Characterized by persistently or recurrently deficient sexual fantasies and desire for sexual activity causing marked distress 4

Female Sexual Dysfunctions

  • Female Sexual Interest/Arousal Disorder (FSIAD): This represents a major change in DSM-5, where the previous separate categories of Hypoactive Sexual Desire Disorder and Female Sexual Arousal Disorder from DSM-IV-TR were combined into a single diagnosis 5, 6. This merger reflects the recognition that desire and arousal are often difficult to differentiate in women.

  • Female Orgasmic Disorder

  • Genito-Pelvic Pain/Penetration Disorder

Important Clinical Considerations

The DSM-5 approach has been criticized for not adequately reflecting clinical reality, particularly regarding FSIAD. Research shows weak correlations between desire and arousal symptoms, suggesting that sexual desire may be better conceptualized as a spectrum rather than categorical diagnoses 5. Most women with sexual dysfunction identify with a circular model of sexual functioning rather than the linear model that underlies DSM-5 classification 5.

Key Diagnostic Features

All sexual dysfunction diagnoses in DSM-5 require:

  • Symptoms present for at least 6 months
  • Causing clinically significant distress
  • Not better explained by another medical condition, substance use, or relationship problems 7, 6

Prevalence Patterns

Sexual dysfunction frequencies vary by subtype and demographic factors. For example, FSIAD affects 8.9% of women ages 18-44,12.3% ages 45-64, and 7.4% over 65 6. Among men, erectile disorder affects 6.2% overall, with rates increasing significantly with age 7.

Common Pitfalls

Avoid assuming that low testosterone automatically explains sexual dysfunction—the majority of patients with sexual dysfunction, particularly those with desire complaints, have normal hormone levels 8. Neurological impairment and psychological factors often play more significant roles than previously appreciated 8.

The DSM-5 removed sexual orientation-related diagnostic categories and reclassified gender incongruence outside of mental disorders, reflecting a non-pathologizing approach to gender and sexual diversity 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.